New themes in the biological functions of 5‐methylcytosine and 5‐hydroxymethylcytosine

5‐methylcytosine (5‐mC) and 5‐hydroxymethylcytosine (5‐hmC) play a critical role in development and normal physiology. Alterations in 5‐mC and 5‐hmC patterns are common events in hematopoietic neoplasms. In this review, we begin by emphasizing the importance of 5‐mC, 5‐hmC, and their enzymatic modifiers in hematological malignancies. Then, we discuss the functions of 5‐mC and 5‐hmC at distinct genic contexts, including promoter regions, gene bodies, intron‐exon boundaries, alternative promoters, and intragenic microRNAs. Recent advances in technology have allowed for the study of 5‐mC and 5‐hmC independently and specifically permitting distinction between the bases that show them to have transcriptional effects that vary by their location relative to gene structure. We extend these observations to their functions at enhancers and transcription factor binding sites. We discuss dietary influences on 5‐mC and 5‐hmC levels and summarize the literature on the effects of folate and vitamin C on 5‐mC and 5‐hmC, respectively. Finally, we discuss how these new themes in the functions of 5‐mC and 5‐hmC will likely influence the broader research field of epigenetics.

[1]  I. Flinn,et al.  Abstract CT103: Clinical safety and activity in a phase I trial of AG-221, a first in class, potent inhibitor of the IDH2-mutant protein, in patients with IDH2 mutant positive advanced hematologic malignancies , 2014 .

[2]  E. Solary,et al.  TET2 Deficiency Inhibits Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem Cells , 2014, Stem cells.

[3]  L. Godley,et al.  The mechanistic role of DNA methylation in myeloid leukemogenesis , 2014, Leukemia.

[4]  R. Wenger,et al.  TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma , 2014, Cell reports.

[5]  Yongtao Guan,et al.  Maternal nutrition at conception modulates DNA methylation of human metastable epialleles , 2014, Nature Communications.

[6]  A. Stark,et al.  Transcriptional enhancers: from properties to genome-wide predictions , 2014, Nature Reviews Genetics.

[7]  Ruiqiang Li,et al.  Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain , 2014, Genome Biology.

[8]  E. Solary,et al.  The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases , 2014, Leukemia.

[9]  Erika L. Moen,et al.  Cancer Biology and Signal Transduction the Role of Gene Body Cytosine Modifications in Mgmt Expression and Sensitivity to Temozolomide , 2022 .

[10]  K. Döhner,et al.  Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications. , 2014, Blood.

[11]  W. Brown,et al.  Single-base resolution of mouse offspring brain methylome reveals epigenome modifications caused by gestational folic acid , 2014, Epigenetics & Chromatin.

[12]  Amit Verma,et al.  Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis. , 2014, Cell reports.

[13]  K. Sugasawa,et al.  PRDM14 promotes active DNA demethylation through the Ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells , 2014, Development.

[14]  William A. Pastor,et al.  Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells , 2014, Proceedings of the National Academy of Sciences.

[15]  Xiaochun Yu,et al.  H2A.B facilitates transcription elongation at methylated CpG loci , 2014, Genome research.

[16]  Lukas Burger,et al.  Transcription Factor Occupancy Can Mediate Active Turnover of DNA Methylation at Regulatory Regions , 2013, PLoS genetics.

[17]  H. Aburatani,et al.  Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders , 2013, The Journal of experimental medicine.

[18]  J. Martín-Subero,et al.  Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. , 2013, Biochimica et biophysica acta.

[19]  G. Pan,et al.  Vitamin C modulates TET1 function during somatic cell reprogramming , 2013, Nature Genetics.

[20]  Pu Zhang,et al.  DNMT1-interacting RNAs block gene specific DNA methylation , 2013, Nature.

[21]  Juan I. Young,et al.  Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate. , 2013, Biochemical and biophysical research communications.

[22]  S. Gore,et al.  Current therapy of myelodysplastic syndromes. , 2013, Blood reviews.

[23]  Stavros Lomvardas,et al.  Alteration of genic 5-hydroxymethylcytosine patterning in olfactory neurons correlates with changes in gene expression and cell identity , 2013, Proceedings of the National Academy of Sciences.

[24]  Wei Zhang,et al.  Genome-Wide Variation of Cytosine Modifications Between European and African Populations and the Implications for Complex Traits , 2013, Genetics.

[25]  J. Qian,et al.  Integrative analysis of tissue-specific methylation and alternative splicing identifies conserved transcription factor binding motifs , 2013, Nucleic acids research.

[26]  Zechen Chong,et al.  Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. , 2013, Journal of the American Chemical Society.

[27]  Mohammad M. Karimi,et al.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells , 2013, Nature.

[28]  Erika L. Moen,et al.  Alterations of 5-Hydroxymethylcytosine in Human Cancers , 2013, Cancers.

[29]  F. Tang,et al.  Dynamics of 5-hydroxymethylcytosine during mouse spermatogenesis , 2013, Nature Communications.

[30]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[31]  Laura E. DeMare,et al.  The genomic landscape of cohesin-associated chromatin interactions , 2013, Genome research.

[32]  Fang Wang,et al.  Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation , 2013, Science.

[33]  O. Abdel-Wahab,et al.  Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. , 2013, Blood.

[34]  P. Jin,et al.  Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming , 2013, Cell.

[35]  Juan I. Young,et al.  Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine*♦ , 2013, The Journal of Biological Chemistry.

[36]  H. Sasaki,et al.  Mouse Oocyte Methylomes at Base Resolution Reveal Genome-Wide Accumulation of Non-CpG Methylation and Role of DNA Methyltransferases , 2013, PLoS genetics.

[37]  D. Odom,et al.  CTCF and Cohesin: Linking Gene Regulatory Elements with Their Targets , 2013, Cell.

[38]  D. Dorsett,et al.  Genome-Wide Control of RNA Polymerase II Activity by Cohesin , 2013, PLoS genetics.

[39]  Xiaodong Cheng,et al.  High-resolution enzymatic mapping of genomic 5-hydroxymethylcytosine in mouse embryonic stem cells. , 2013, Cell reports.

[40]  J. Jui,et al.  Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. , 2013, Cell reports.

[41]  Frank Lyko,et al.  Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. , 2013, Developmental cell.

[42]  W. Reik,et al.  Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency , 2013, Nature.

[43]  N. Heintz,et al.  MeCP2 binds to 5hmc enriched within active genes and accessible chromatin in the nervous system , 2012, Cell.

[44]  Masao Nagasaki,et al.  Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms , 2012, Nature Genetics.

[45]  A. Iwama,et al.  TET2 is essential for survival and hematopoietic stem cell homeostasis , 2012, Leukemia.

[46]  B. Blencowe,et al.  5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary , 2012, Nature Structural &Molecular Biology.

[47]  D. Dolinoy,et al.  Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. , 2012, The Journal of nutritional biochemistry.

[48]  M. Minden,et al.  Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  Michael D. Wilson,et al.  Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules , 2012, Genome research.

[50]  J. Eeckhoute,et al.  Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers , 2012, Nucleic acids research.

[51]  G. Hon,et al.  Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome , 2012, Cell.

[52]  A. Ly,et al.  Folate and DNA methylation. , 2012, Antioxidants & redox signaling.

[53]  I. Korf,et al.  R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. , 2012, Molecular cell.

[54]  G. Robinson,et al.  DNA methylation dynamics, metabolic fluxes, gene splicing, and alternative phenotypes in honey bees , 2012, Proceedings of the National Academy of Sciences.

[55]  M. Caligiuri,et al.  Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  Vijay K. Tiwari,et al.  DNA-binding factors shape the mouse methylome at distal regulatory regions , 2011, Nature.

[57]  Peng Jin,et al.  5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging , 2011, Nature Neuroscience.

[58]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[59]  R. Sandberg,et al.  CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing , 2011, Nature.

[60]  Feng-Chun Yang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[61]  Z. Deng,et al.  The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes , 2011, Nature.

[62]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[63]  Yang Wang,et al.  Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA , 2011, Science.

[64]  K. Rajewsky,et al.  Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.

[65]  Peter A. Jones,et al.  OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes , 2011, Proceedings of the National Academy of Sciences.

[66]  J. Stamatoyannopoulos,et al.  DNA methylation status predicts cell type‐specific enhancer activity , 2011, The EMBO journal.

[67]  A. Klungland,et al.  The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. , 2011, Biochemical and biophysical research communications.

[68]  K. Wagner,et al.  Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[70]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[71]  Omar Abdel-Wahab,et al.  Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy , 2011, Advances in hematology.

[72]  Suhua Feng,et al.  5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells , 2011, Genome Biology.

[73]  B. Ren,et al.  Integrating 5-Hydroxymethylcytosine into the Epigenomic Landscape of Human Embryonic Stem Cells , 2011, PLoS genetics.

[74]  Philipp Kapranov,et al.  Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells , 2011, Nature.

[75]  Q. Lu,et al.  MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. , 2011, Arthritis and rheumatism.

[76]  G. Ming,et al.  Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain , 2011, Cell.

[77]  G. Pfeifer,et al.  Relationship between Gene Body DNA Methylation and Intragenic H3K9me3 and H3K36me3 Chromatin Marks , 2011, PloS one.

[78]  Juri Rappsilber,et al.  TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity , 2011, Nature.

[79]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[80]  Yong-mei Zhu,et al.  Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.

[81]  Keji Zhao,et al.  Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. , 2011, Genes & development.

[82]  J. Licht,et al.  DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.

[83]  W. Reik,et al.  5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. , 2011, Nature communications.

[84]  F. Lyko,et al.  Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines , 2011, PloS one.

[85]  G. Pfeifer,et al.  Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine , 2011, Proceedings of the National Academy of Sciences.

[86]  Riitta Lahesmaa,et al.  Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. , 2011, Cell stem cell.

[87]  C. Schofield,et al.  Structural studies on human 2-oxoglutarate dependent oxygenases. , 2010, Current opinion in structural biology.

[88]  S. Forêt,et al.  The Honey Bee Epigenomes: Differential Methylation of Brain DNA in Queens and Workers , 2010, PLoS biology.

[89]  I. Grummt,et al.  Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. , 2010, Genes & development.

[90]  C. Croce,et al.  Interplay between microRNAs and the epigenetic machinery: an intricate network. , 2010, Biochimica et biophysica acta.

[91]  Peter A. Jones,et al.  H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes. , 2010, Molecular cell.

[92]  H. Blom,et al.  Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects , 2010, Journal of Inherited Metabolic Disease.

[93]  D. Birnbaum,et al.  Alteration of cohesin genes in myeloid diseases , 2010, American journal of hematology.

[94]  Yi Zhang,et al.  Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification , 2010, Nature.

[95]  M. Pellegrini,et al.  Relationship between nucleosome positioning and DNA methylation , 2010, Nature.

[96]  Allen D. Delaney,et al.  Conserved Role of Intragenic DNA Methylation in Regulating Alternative Promoters , 2010, Nature.

[97]  J. Choi.  Contrasting chromatin organization of CpG islands and exons in the human genome , 2010, Genome Biology.

[98]  T. Naoe,et al.  Array-based genomic resequencing of human leukemia , 2010, Oncogene.

[99]  M. Caligiuri,et al.  IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  Swati Kadam,et al.  Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine , 2010, Nucleic acids research.

[101]  Petra C. Schwalie,et al.  A CTCF-independent role for cohesin in tissue-specific transcription. , 2010, Genome research.

[102]  Chia-Lin Wei,et al.  Dynamic changes in the human methylome during differentiation. , 2010, Genome research.

[103]  David R. Liu,et al.  The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing , 2010, PloS one.

[104]  R. Stam,et al.  Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. , 2009, Blood.

[105]  J. Soulier,et al.  Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.

[106]  Martin J Aryee,et al.  Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.

[107]  N. Heintz,et al.  The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.

[108]  Madeleine P. Ball,et al.  Corrigendum: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells , 2009, Nature Biotechnology.

[109]  Valeria Santini,et al.  Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. , 2009, The Lancet. Oncology.

[110]  C. O'keefe,et al.  Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. , 2009, Blood.

[111]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[112]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[113]  H. Nagase,et al.  Epigenetics: differential DNA methylation in mammalian somatic tissues , 2008, The FEBS journal.

[114]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[115]  Xiaodong Cheng,et al.  Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation , 2007, Nature.

[116]  C. Allis,et al.  DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.

[117]  M. Fraga,et al.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. , 2007, Cancer research.

[118]  John M Bennett,et al.  Decitabine improves patient outcomes in myelodysplastic syndromes , 2006, Cancer.

[119]  D. Brutlag,et al.  A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[120]  K. Nakai,et al.  Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. , 2005, Genome research.

[121]  V. Rakyan,et al.  Metastable epialleles in mammals. , 2002, Trends in genetics : TIG.

[122]  J. Holland,et al.  Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  J. Dekker,et al.  Capturing Chromosome Conformation , 2002, Science.

[124]  Gangning Liang,et al.  Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements , 2002, Molecular and Cellular Biology.

[125]  S. Groshen,et al.  Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. , 2001, Journal of the National Cancer Institute.

[126]  S. Clark,et al.  Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. , 1999, Cancer research.

[127]  R. Kodell,et al.  Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[128]  R. Jaenisch,et al.  RNA and the Epigenetic Regulation of X Chromosome Inactivation , 1998, Cell.

[129]  M. Davisson,et al.  Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage. , 1994, Genes & development.

[130]  G. Martin,et al.  Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation , 1987, Cell.

[131]  A. Morley,et al.  Delayed DNA methylation is an integral feature of DNA replication in mammalian cells. , 1986, Experimental cell research.

[132]  Joshua F. McMichael,et al.  DNMT 3 A mutations in acute myeloid leukemia , 2016 .

[133]  Boris Lenhard,et al.  Cohesin-based chromatin interactions enable regulated gene expression within preexisting architectural compartments , 2013, Genome research.

[134]  L. Godley,et al.  Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies. , 2013, Seminars in hematology.

[135]  L. Bailey,et al.  Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. , 2012, Advances in nutrition.

[136]  Chieh-Yu Liu,et al.  Clinical Trials and Observations , 2022 .

[137]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[138]  J. Herman,et al.  The fundamental role of epigenetics in hematopoietic malignancies. , 2006, Blood reviews.

[139]  K. Akashi,et al.  Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. , 2001, Blood.

[140]  P. Jones,et al.  The DNA methylation paradox. , 1999, Trends in genetics : TIG.

[141]  M. Bartolomei,et al.  Genomic imprinting in mammals. , 1997, Annual review of genetics.

[142]  S. Andrews,et al.  Dynamic stage-specific changes in imprinted differentially methylated regions during early mammalian development and prevalence of non-CpG methylation in oocytes , 2022 .